Jie Eun Lee1. 1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea. mdjelee@hallym.or.kr.
As the prevalence of obesity increases, so does the burden of its associated comorbidities, such as myocardial infarction (MI) and ischemic stroke (IS). According to the Fact Sheet from the Korean Society for the Study of Obesity, medical expenses increase proportionally with body mass index (BMI) and waist circumference (WC) in both men and women [1]. Therefore, it is important to identify people at highrisk of obesity and its related comorbidities.BMI is one of the most frequently used surrogate indicators ofobesity that reflects total body fat. However, both total body fat and fat distribution pattern are important when predicting the risk of cardiovascular diseases (CVD). The fat distribution pattern is determined by anthropometric measures, such as the WC, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), and sagittal abdominal diameter [23]. These anthropometric indices areassociated with, and may be predictors of, CVD [456], but these associations remain controversial.At any given WC, Asian people have greater visceral fat compared with Europeans, and a tighter threshold of WC might be needed to determine the risk [789]. However, combining various ethnic groups under asingle “Asian” category might obscure important differences in groups. One study of about 15,000 Korean patients found no significant difference between WC and BMI in predicting the incidence of CVD [10], but a later study of 5,500 Koreans in 2009 found that WC and WHtR were superior to BMI [11].The results of a recent study have important clinical significance for the Korean population. Using the data of more than 20 million Koreans from the National Health Insurance Service (NHIS), Cho et al. [12] confirmed that WC is a better marker for predicting the incidence of MI or IS than BMI. They also reported the appropriate WC cutoffs for predicting the risk of CVD; the optimal cutoffs were 84/85 cm for men (MI/IS, respectively) and 78 cm for women (both), which are lower than the current recommended cutoffs. In addition, the WC cutoff in the study by Cho et al. [12] is 10 cm lower than the global standard set by the World Health Organization for men [13]. These new values suggest that closer attention should be given to earlier identification and management of overweight/obesity for better CVD prevention. The study by Cho et al. [12] found smaller differences in the optimal cutoffs from the current recommendation in women. However, the authors noted that the incidence rates of MI or IS increases more steeply as WC increases [12]. Therefore, clinicians should be more alert to elevated abdominal circumference in both men and women.Despite the possible differences from the actual incidence of CVD associated with the use of NHIS data and the relatively short follow-up period in the study by Cho et al. [12], this study included the largest number of Koreans to date, and its findings are of high clinical significance. Although BMI is still used as a standard to diagnose obesity, clinicians should be aware that a person with a ‘high’ WC, even when the BMI is in the ‘healthy’ range, may still have a higher risk of CVD.WC is a non-invasive, easily measurable anthropometric index, but it is prone to technical error of measurement from inter-measurer error. Therefore, it would be clinically useful to compare WC alone with other anthropometric indices reflecting central obesity such as WHR or WHtR in predicting the incidence of CVD.
Authors: Harald J Schneider; Nele Friedrich; Jens Klotsche; Lars Pieper; Matthias Nauck; Ulrich John; Marcus Dörr; Stephan Felix; Hendrik Lehnert; David Pittrow; Sigmund Silber; Henry Völzke; Günter K Stalla; Henri Wallaschofski; Hans-Ulrich Wittchen Journal: J Clin Endocrinol Metab Date: 2010-02-03 Impact factor: 5.958
Authors: Kee C Cheong; Sumarni M Ghazali; Lim K Hock; Soobitha Subenthiran; Teh C Huey; Lim K Kuay; Feisul I Mustapha; Ahmad F Yusoff; Amal N Mustafa Journal: Diabetes Metab Syndr Date: 2015-03-06
Authors: K Rådholm; A Tengblad; E Dahlén; T Länne; J Engvall; F H Nystrom; C J Östgren Journal: Nutr Metab Cardiovasc Dis Date: 2017-02-16 Impact factor: 4.222
Authors: Ellen W Demerath; Shumei S Sun; Nikki Rogers; Miryoung Lee; Derek Reed; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne Journal: Obesity (Silver Spring) Date: 2007-12 Impact factor: 5.002
Authors: Scott A Lear; Karin H Humphries; Simi Kohli; Arun Chockalingam; Jiri J Frohlich; C Laird Birmingham Journal: Am J Clin Nutr Date: 2007-08 Impact factor: 7.045
Authors: Devine S Frundi; Eva Kettig; Lena Luise Popp; Melanie Hoffman; Marine Dumartin; Magali Hughes; Edgar Lamy; Yvonne Joko Walburga Fru; Arjola Bano; Taulant Muka; Matthias Wilhelm Journal: Front Cardiovasc Med Date: 2022-07-22
Authors: Alan E Guzmán-León; Ana G Velarde; Milca Vidal-Salas; Lucía G Urquijo-Ruiz; Luz A Caraveo-Gutiérrez; Mauro E Valencia Journal: PLoS One Date: 2019-12-31 Impact factor: 3.240